Bentham Science Logo


S.No. Title Source Title Authors DOI Citing Works Count
1 Neuroprotective Effects of Medicinal Plants in Cerebral Hypoxia and Anoxia: A Systematic Review The Natural Products Journal Nasibeh Amirzargar; Saeid Heidari-Soureshjani; Qian Yang; Saber Abbaszadeh; Mojtaba Khaksarian 10.2174/2210315509666190820103658 0
2 Novel Drugs Targeting the SARS-CoV-2/COVID-19 Machinery. Current Topics In Medicinal Chemistry Ariane Sternberg; Dwight L. McKee; Cord Naujokat 10.2174/1568026620999200517043137 9
3 The Microbiome: A Reservoir to Discover New Antimicrobials Agents. Current Topics In Medicinal Chemistry Sébastien Boutin; Alexander H. Dalpke 10.2174/1568026620666200320112731 0
4 Carnosine and Diabetic Nephropathy Current Medicinal Chemistry Verena Peters; Benito A. Yard; Claus Peter Schmitt 10.2174/0929867326666190326111851 7
5 The "Big Five" Phytochemicals Targeting Cancer Stem Cells: Curcumin, EGCG, Sulforaphane, Resveratrol and Genistein Current Medicinal Chemistry Cord Naujokat; Dwight L. McKee 10.2174/0929867327666200228110738 7
6 The Effect of PDE5 Inhibitors on the Male Reproductive Tract. Current Pharmaceutical Design Nikolaos Sofikitis; A. Kaltsas; Fotios Dimitriadis; Jens Rassweiler; Nikolaos Grivas; A. Zachariou; Apostolos Kaponis; Panagiota Tsounapi; Napoleon Paterakis; Andreas Karagiannis; Sotirios Skouros; Ioannis Giannakis; Ioannis Champilomatis; Minas Paschopou 10.2174/1381612826666200226121510 3
7 Vascular Damage in Obesity and Diabetes: Highlighting Links Between Endothelial Dysfunction and Metabolic Disease in Zebrafish and Man. Current Vascular Pharmacology Lucas M Wiggenhauser; Jens Kroll 10.2174/1570161116666181031101413 6
8 Overview of Genomic Tools for Circular Visualization in the Next-generation Genomic Sequencing Era. Current Genomics Alisha Parveen; Sukant Khurana; Abhishek Kumar 10.2174/1389202920666190314092044 1
9 Modulation of ABC Transporters by Nuclear Receptors: Physiological, Pathological and Pharmacological Aspects. Current Medicinal Chemistry Juan Pablo Rigalli; Guillermo Nicolás Tocchetti; Johanna Weiss 10.2174/0929867324666170920141707 9
10 An Overview of Targeted Alpha Therapy with 225Actinium and 213Bismuth. Current Radiopharmaceuticals Alfred Morgenstern; Christos Apostolidis; Clemens Kratochwil; Mike Sathekge; Leszek Królicki; Frank Bruchertseifer 10.2174/1874471011666180502104524 64
11 Protein and Peptide Studies in Kidney Disease: Prediction, Diagnosis and Treatment. Protein And Peptide Letters Jiaguo Huang 10.2174/092986652506180810154427 0
12 Optimization of Protein and Peptide Drugs Based on the Mechanisms of Kidney Clearance. Protein And Peptide Letters Huizi Wu; Jiaguo Huang 10.2174/0929866525666180530122835 7
13 AMPA Receptor Antagonist CFM-2 Decreases Survivin Expression in Cancer Cells. Anti-cancer Agents In Medicinal Chemistry Domingo Sanchez Ruiz; Hella Luksch; Marco Sifringer; Achim Temme; Christian Staufner; Wojciech Rzeski; Jenny Marzahn; Aneta Grabarska; Chrysanthy Ikonomidou; Andrzej Stepulak 10.2174/1871520618666180228123406 3
14 Drug-Induced Nephrotoxicity and Drug Metabolism in Renal Failure. Current Drug Metabolism Jiaguo Huang 10.2174/138920021907180709121120 2
15 Drug-Induced Nephrotoxicity: Pathogenic Mechanisms, Biomarkers and Prevention Strategies Current Drug Metabolism Huizi Wu; Jiaguo Huang 10.2174/1389200218666171108154419 13
16 Sodium-glucose Cotransporter 2 Inhibitors: Glucose Lowering Against other Hypoglycemic Agents. Cardiovascular & Hematological Disorders Drug Targets Konstantinos Avranas; Konstantinos Imprialos; Konstantinos Stavropoulos; Georgios Lales; Alexandos Manafis; Anastasia Skalkou; Lars P. Kihm 10.2174/1871529x18666180206160838 3
17 Sodium-glucose Cotransporter 2 Inhibitors and the Risk of Diabetic Ketoacidosis; from Pathophysiology to Clinical Practice. Cardiovascular & Hematological Disorders Drug Targets Dimitrios Patoulias; Alexandros Manafis; Christos Mitas; Konstantinos Avranas; Georgios Lales; Ioanna Zografou; Christos Sambanis; Asterios Karagiannis 10.2174/1871529x18666180206123149 10
18 Human Disease-Protein Network Current Proteomics Yangmei Cheng; Hao Zhang; Hui Zheng; Jun Zhang; Yang Hu; Liang Cheng 10.2174/1570164614666171031154904 0
19 Essential Oil Composition, In Vivo Antioxidant, and Antimicrobial Activities of Pimpinella pruatjan from West Java, Indonesia The Natural Products Journal Agustina D.R. Nurcahyanti; Issam J. Nasser; Frank Sporer; Bernhard Wetterauer; Ireng D. Kadarso; Jürgen Reichling; Michael Wink 10.2174/2210315507666170620093210 4
20 Editorial: Targeting of Cancer Cells and Tumor Microenvironment: Perspectives for Personalized Therapy. Current Pharmaceutical Design Julia Kzhyshkowska; Mariano Bizzarri; Ron N. Apte; Nadezhda V. Cherdyntseva 10.2174/138161282332171221165319 3
21 Multicyclic Peptides as Scaffolds for the Development of Tumor Targeting Agents Current Medicinal Chemistry Anastasia Loktev; Uwe Haberkorn; Walter Mier 10.2174/0929867324666170316120304 4
22 High Sensitivity Troponin I and T Reflect the Presence of Obstructive and Multi-Vessel Coronary Artery Disease Being Assessed by Coronary Computed Tomography Angiography. Current Pharmaceutical Biotechnology Nadine Reckord; Michael Behnes; Michele Natale; Agnibh Mukherji; Jonas Rusnak; Uzair Ansari; Siegfried Lang; Ursula Hoffmann; Martin Borggrefe; Thomas Henzler; Michael Neumaier; Maximilian Kittel; Kambis Mashayekhi; Thomas Bertsch; Ibrahim Akin 10.2174/1389201018666170601082145 5
23 Biomarkers in Cardiomyopathies and Prediction of Sudden Cardiac Death. Current Pharmaceutical Biotechnology M. Kruska; Ibrahim El-Battrawy; Michael Behnes; Martin Borggrefe; Ibrahim Akin 10.2174/1389201018666170623125842 6
24 Biomarkers in Stable Coronary Artery Disease. Current Pharmaceutical Biotechnology Jonas Rusnak; Christian Fastner; Michael Behnes; Kambis Mashayekhi; Martin Borggrefe; Ibrahim Akin 10.2174/1389201018666170630120805 7
25 The Use of Biomarkers in Sepsis: A Systematic Review. Current Pharmaceutical Biotechnology K. Giannakopoulos; Ursula Hoffmann; Uzair Ansari; Thomas Bertsch; Martin Borggrefe; Ibrahim Akin; Michael Behnes 10.2174/1389201018666170601080111 17
26 Contribution and Value of Biomarkers in Acute Aortic Syndromes. Current Pharmaceutical Biotechnology Mustafa Yildiz; Dogac Oksen; Michael Behnes; Ibrahim Akin 10.2174/1389201018666170615081727 3
27 An Expanding Role of Biomarkers in Pulmonary Arterial Hypertension. Current Pharmaceutical Biotechnology Mustafa Yildiz; Alparslan Sahin; Michael Behnes; Ibrahim Akin 10.2174/1389201018666170615082510 6
28 Editorial: Circulating Biomarkers in Cardiovascular Diseases - A Field of Theoretical Research or Realistic Clinical Application? Current Pharmaceutical Biotechnology Michael Behnes; Ibrahim Akin 10.2174/138920101806170815094207 1
29 Advantages and Limitations of Current Biomarker Research: From Experimental Research to Clinical Application. Current Pharmaceutical Biotechnology Seung-Hyun Kim; Christel Weiß; Ursula Hoffmann; Martin Borggrefe; Ibrahim Akin; Michael Behnes 10.2174/1389201018666170601091205 7
30 Clinically Relevant Biomarkers in Acute Heart Failure: An Update. Current Pharmaceutical Biotechnology Agnibh Mukherji; Uzair Ansari; Martin Borggrefe; Ibrahim Akin; Michael Behnes 10.2174/1389201018666170623090817 2
31 The Two Faces of Interleukin-17A in Atherosclerosis. Current Drug Targets Mohammadreza Akhavanpoor; Hamidreza Akhavanpoor; Christian A. Gleissner; Susanne Wangler; Andreas O Doesch; Hugo A. Katus; Christian Erbel 10.2174/1389450117666161229142155 7
32 Genetic Imbalance in Patients with Cervical Artery Dissection. Current Genomics Caspar Grond-Ginsbach; Bowang Chen; Michael Krawczak; Rastislav Pjontek; Philip Ginsbach; Yanxiang Jiang; Sherine Abboud; M. Arnold; Anna Bersano; Tobias Brandt; Valeria Caso; Stéphanie Debette; Martin Dichgans; Andreas Geschwendtner; Giacomo Giaca 10.2174/1389202917666160805152627 15
33 L-Canavanine Potentiates Cytotoxicity of Chemotherapeutic Drugs in Human Breast Cancer Cells. Anti-cancer Agents In Medicinal Chemistry Agustina D.R. Nurcahyanti; Michael Wink 10.2174/1871520616666160223111551 2
34 One Stage Bilateral Total Hip Arthroplasty in Siblings with Larsen Syndrome. The Open Orthopaedics Journal Christian Merle; Wenzel Waldstein; Joseph D. Lipman; Maximilian F. Kasparek; Friedrich Boettner 10.2174/1874325001610010569 1
35 PEGylated Peptide-Based Imaging Agents for Targeted Molecular Imaging. Current Protein & Peptide Science Huizi Wu; Jiaguo Huang 10.2174/1389203717666160101123832 6
36 Tumor Stroma Manipulation By MSC Current Drug Targets Giulia Grisendi; Carlotta Spano; Filippo Rossignoli; Naomi D’souza; Giulia Golinelli; Agnese Fiori; Edwin M. Horwitz; Valentina Guarneri; Federico Piacentini; Paolo Paolucci; Massimo Dominici 10.2174/1389450117666160307143226 8
37 A Comprehensive Review on the Genetic Regulation of Cisplatin-induced Nephrotoxicity Current Genomics Zeneida Herrera-Pérez; Norbert Gretz; Harsh Dweep 10.2174/1389202917666160202220555 17
38 The Early Bird Catches the Worm – Can Evolution Teach us Lessons in Fighting HIV? Current HIV Research Torsten Schaller; Nikolas Herold 10.2174/1570162x14999160224094914 4
39 The Use of Novel Oral Anticoagulants in Atrial Fibrillation Cardiovascular & Hematological Disorders Drug Targets Uzair Ansari; Michael Behnes; Christian Fastner; Ibrahim Akin 10.2174/1871529x1502151209111019 1
40 New Oral Anticoagulation after Heart Valve Replacement. Cardiovascular & Hematological Disorders Drug Targets Ibrahim El-Battrawy; Stefan Baumann; Aydin Huseynov; Ibrahim Akin 10.2174/1871529x1502151209111735 1
41 Novel Oral Anticoagulation Laboratory Monitoring, Interaction and Treatment of Complications. Cardiovascular & Hematological Disorders Drug Targets Aydin Huseynov; Stefan Baumann; Ibrahim El-Battrawy; Ibrahim Akin 10.2174/1871529x1502151209112437 0
42 New Oral Anticoagulants in Coronary Artery Disease. Cardiovascular & Hematological Disorders Drug Targets Michael Behnes; Christian Fastner; Uzair Ansari; Ibrahim Akin 10.2174/1871529x1502151209111429 4
43 Novel Oral Anticoagulation During Pulmonary Vein Isolation and Cardioversion. Cardiovascular & Hematological Disorders Drug Targets Christian Fastner; Michael Behnes; Uzair Ansari; Ibrahim Akin 10.2174/1871529x1502151209112128 0
44 Successful Combination of Sequential Gene Therapy and Rescue Allo-HSCT in Two Children with X-CGD - Importance of Timing Current Gene Therapy Ulrich Siler; Anna Paruzynski; Heidi Holtgreve-Grez; Elena Kuzmenko; Ulrike Koehl; E.D. Renner; Canan Alhan; Arjan A. van de Loosdrecht; Joachim Schwäble; Thomas Pfluger; Joelle Tchinda; Markus Schmugge; Anna Jauch; Sonja Naundorf; Klaus Kühlcke 10.2174/1566523215666150515145255 42
45 A Structural Feature of the Non-Peptide Ligand Interactions with Mice Mu-Opioid Receptors Current Computer-aided Drug Design Hamid R. Noori; Christian Mücksch; Herbert M. Urbassek 10.2174/1573409910666141031093504 4
46 Mouse models of autoimmune diseases - autoimmune myocarditis. Current Pharmaceutical Design Anna-Maria Müller; Andrea Fischer; Hugo A. Katus; Ziya Kaya 10.2174/1381612821666150316123711 14
47 Synergistic antimicrobial activity of combinations of sanguinarine and EDTA with vancomycin against multidrug resistant bacteria. Drug Metabolism Letters Razan Hamoud; Jürgen Reichling; Michael Wink 10.2174/187231280802150212100742 19
48 Rational Design of CPP-based Drug Delivery Systems: Considerations from Pharmacokinetics Current Pharmaceutical Biotechnology Arite Mickan; Dikran Sarko; Uwe Haberkorn; Walter Mier 10.2174/138920101503140822101814 9
49 Recent developments in drug-eluting coronary stents. Cardiovascular & Hematological Disorders Drug Targets Mustafa Yildiz; Banu Sahin Yildiz; Mustafa Ozan Gürsoy; Ibrahim Akin 10.2174/1871529x14666140823121609 4
50 Deciphering the Systems Biology of mTOR Inhibition by Integrative Transcriptome Analysis Current Pharmaceutical Design Sophie Domhan; Christian Schwager; Quanxiang Wei; Stefan Muschal; Claudia Sommerer; Christian Morath; Wolfgang Wick; Christian Maercker; Jürgen Debus; Martin Zeier; Peter E. Huber; Amir Abdollahi 10.2174/138161282001140113125549 15
51 Novel Monocyte Biomarkers of Atherogenic Conditions Current Pharmaceutical Design Alexei Gratchev; Ilja Ovsiy; Ioannis Manousaridis; Vladimir Riabov; Alexander N. Orekhov; Julia Kzhyshkowska 10.2174/1381612811319330004 15
52 Reactive Oxygen Species in Cancer Biology and Anticancer Therapy Current Medicinal Chemistry Yuhui Yang; Svetlana Karakhanova; Jens Werner; Alexandr V. Bazhin 10.2174/0929867311320999165 84
53 In-Silico Algorithms for the Screening of Possible microRNA Binding Sites and Their Interactions. Current Genomics Harsh Dweep; Carsten Sticht; Norbert Gretz 10.2174/1389202911314020005 52
54 Vitamin D and Cancer Mortality: Systematic Review of Prospective Epidemiological Studies Anti-cancer Agents In Medicinal Chemistry Stefan Pilz; Katharina Kienreich; Andreas Tomaschitz; Eberhard Ritz; Elisabeth Lerchbaum; Barbara Obermayer-Pietsch; Veronika Matzi; Joerg Lindenmann; Winfried März; Sara Gandini; Jacqueline M. Dekker 10.2174/187152013804487407 55
55 Diagnostic Tests for the Detection of Human Papillomavirus-associated Cervical Lesions Current Pharmaceutical Design Miriam Reuschenbach; Magnus von Knebel Doeberitz 10.2174/1381612811319080002; 10.2174/138161213804805612 9
56 Delayed cerebral ischemia after subarachnoid hemorrhage: from vascular spasm to cortical spreading depolarizations. Current Neurovascular Research Zelong Zheng; Renán Sánchez-Porras; Edgar Santos; Andreas Unterberg; Oliver W. Sakowitz 10.2174/156720212803530663 9
57 Anandamide dysfunction in prodromal and established psychosis. Current Pharmaceutical Design F. Markus Leweke 10.2174/138161212802884843 20
58 Potential protective effects of cannabidiol on neuroanatomical alterations in cannabis users and psychosis: a critical review. Current Pharmaceutical Design Derik Hermann; Miriam Schneider 10.2174/138161212802884825 36
59 Postnatal Neurogenesis and Dopamine Alterations in Early Psychosis Recent Patents On CNS Drug Discovery Dragos Inta; Juan M. Lima-Ojeda; Peter Gass; Paolo Fusar-Poli 10.2174/157488912803251998 8
60 MicroRNAs in cancer: small molecules, big chances. Anti-cancer Agents In Medicinal Chemistry Mohammed Abba; Giridhar Mudduluru; Heike Allgayer 10.2174/187152012802650273 28
61 Platelet-Derived Chemokines in Atherogenesis: What’s New? Current Vascular Pharmacology Christian A. Gleissner 10.2174/157016112801784521 17
62 Bifunctional chelators in the design and application of radiopharmaceuticals for oncological diseases. Current Medicinal Chemistry Dikran Sarko; Michael Eisenhut; Uwe Haberkorn; Walter Mier 10.2174/092986712800609751 26
63 Hippocampal morphology and autobiographic memory in mild cognitive impairment and Alzheimer's disease. Current Alzheimer Research Philipp A. Thomann; Ulrich Seidl; Julia Brinkmann; Dusan Hirjak; Tanja V. Traeger; R. Christian Wolf; Marco Essig; Johannes Schrode 10.2174/156720512800492558 21
64 Evolution of global and local grey matter atrophy on serial MRI scans during the progression from MCI to AD. Current Alzheimer Research Gabriela Spulber; Eini Niskanen; Stuart W. S. MacDonald; Miia Kivipelto; Daniel Ferreira Padilla; Valtteri Julkunen; Merja Hallikainen; Ritva Vanninen; Lars-Olof Wahlund; Hilkka Soininen 10.2174/156720512800492486 40
65 Microbubbles as a vehicle for gene and drug delivery: current clinical implications and future perspectives. Current Pharmaceutical Design Nicolas Geis; Hugo A. Katus; Raffi Bekeredjian 10.2174/138161212800099946 73
66 Why and how do microbubbles enhance the effectiveness of diagnostic and therapeutic interventions in cerebrovascular disease Current Pharmaceutical Design Stephen Meairs; Rolf Kern; Angelika Alonso 10.2174/138161212800099982 8
67 Immune Reconstitution During the First Year of Antiretroviral Therapy of HIV-1-Infected Adults in Rural Burkina Faso The Open AIDS Journal Fabrice Tiba; Frans Nauwelaers; Siaka Traoré; Boubacar Coulibaly; Thierry Ouedraogo; Adama Compaore; Hans-Georg Kräusslich; Thomas Böhler 10.2174/1874613601206010016 6
68 What can we learn from single molecule trajectories Current Protein & Peptide Science Verena Ruprecht; Markus Axmann; Stefan Wieser; Gerhard J. Schütz 10.2174/138920311798841753 7
69 E-health for individualized prevention of eating disorders. Clinical Practice And Epidemiology In Mental Health : CP & EMH Katajun Lindenberg; Markus Moessner; Joanna Harney; Orla McLaughlin; Stephanie Bauer 10.2174/1745017901107010074 28
70 Regulation of gene expression by retinoids. Current Medicinal Chemistry Philipp M. Amann; Stefan B. Eichmüller; Jan Schmidt; Alexandr V. Bazhin 10.2174/092986711795029618 53
71 Vaccination and antiviral treatment of neglected diseases caused by flaviviral infections. Current Medicinal Chemistry K. Schleich; Cindy Nürnberger; A. Sobanski; Thomas Efferth 10.2174/092986711794480168 9
72 Current treatment concepts of CML. Current Cancer Drug Targets Armin Leitner; Andreas Hochhaus; Martin C. Müller 10.2174/156800911793743637 17
73 Inhibition of Membrane Complement Inhibitor Expression (CD46, CD55, CD59) by siRNA Sensitizes Tumor Cells to Complement Attack In Vitro Current Cancer Drug Targets Nicolas Geis; Stefanie Zell; Renate Rutz; Wenhan Li; Thomas Giese; Srinivas Mamidi; Stefan Schultz; Michael Kirschfink 10.2174/156800910793357952 43
74 Acamprosate: how, where, and for whom does it work? Mechanism of action, treatment targets, and individualized therapy. Current Pharmaceutical Design Falk Kiefer; Karl Mann 10.2174/138161210791516341 51
75 Trypanosomatid parasites causing neglected diseases. Current Medicinal Chemistry Kathrin Nussbaum; J. Honek; C. M. C.v.C. Cadmus; Thomas Efferth 10.2174/092986710790979953 60
76 You Cannot Have Your Cake and Eat It, too: How Induced Goal Conflicts Affect Complex Problem Solving The Open Psychology Journal Christine Blech; Joachim Funke 10.2174/1874350101003010042 21
77 Subjective Outcomes Assessment in Chronic Rhinosinusitis The Open Otorhinolaryngology Journal Ingo Baumann 10.2174/1874428101004010028 9
78 Evaluation of Quality of Life in Patients Treated with Traditional Chinese Medicine The Open Otorhinolaryngology Journal Serkan Sertel; Henry Johannes Greten; Hans-Joachim Kraemer; Thomas Efferth; Peter K. Plinkert; Ingo Baumann 10.2174/1874428101004010062 8
79 Benzamides as melanotropic carriers for radioisotopes, metals, cytotoxic agents and as enzyme inhibitors. Current Medicinal Chemistry Doerte Oltmanns; Michael Eisenhut; Walter Mier; Uwe Haberkorn 10.2174/092986709788612684 12
80 On wage policies and unemployment The Open Economics Journal Andreas Irmen 10.2174/1874919400902010039 0
81 The association of connective tissue disorders with cervical artery dissections. Current Molecular Medicine Caspar Grond-Ginsbach; Stéphanie Debette 10.2174/156652409787581547 49
82 Hemichannels in cerebral ischemia Current Molecular Medicine Panagiotis Bargiotas; Hannah Monyer; Markus Schwaninger 10.2174/156652409787581646 52
83 Oxygen therapy in acute ischemic stroke - experimental efficacy and molecular mechanisms. Current Molecular Medicine Sven Poli; Roland Veltkamp 10.2174/156652409787581619 46
84 Targeting Histone Deacetylases in Neuroblastoma Current Pharmaceutical Design Olaf Witt; Hedwig E. Deubzer; M Lodrini; Till Milde; I. Oehme 10.2174/138161209787315774 52
85 Cross-clade recognition of HIV-1 CAp24 by CD4+ T cells in HIV-1-infected individuals in Burkina Faso and Germany. The Open AIDS Journal Thomas Böhler; Vanessa Mrosek; Kerstin Müller; Paul Schnitzler; Martin Hartmann; Thierry Ouedraogo; B. Coulibaly; Ali Sié; Vanda Bartonova; Denis M. Tebit; Hans-Georg Kräusslich 10.2174/1874613600903010004 1
86 Evolutionary advantage and molecular modes of action of multi-component mixtures used in phytomedicine. Current Drug Metabolism Michael Wink 10.2174/138920008786927794 209
87 Molecular mechanisms underlying St. John's wort drug interactions. Current Drug Metabolism Maike Kober; Kerstin Pohl; Thomas Efferth 10.2174/138920008786927767 51
88 Community Perceptions on Different Delivery Mechanisms for Insecticide- Treated Bed Nets in Rural Burkina Faso The Open Public Health Journal Claudia Beiersmann; Manuela De Allegri; Mamadou Sanon; Justin Tiendrebéogo; Albrecht Jahn; Olaf Mueller 10.2174/1874944500801010017 5
89 Novel Systemic Markers for Patients with Alzheimer Disease? – A Pilot Study Current Alzheimer Research Stefan S. Kassner; Gabriel A. Bonaterra; Elmar Kaiser; Wulf Hildebrandt; Jürgen Metz; Johannes Schröder; Ralf Kinscherf 10.2174/156720508785132253 29
90 Antibody-Targeted RNase Fusion Proteins (ImmunoRNases) for Cancer Therapy Current Pharmaceutical Biotechnology Jürgen Krauss; Michaela A. E. Arndt; Stefan Dübel; Susanna M. Rybak 10.2174/138920108784567317 15
91 Immunotherapy of pancreatic carcinoma. Reviews On Recent Clinical Trials Angela Märten 10.2174/157488708784223826 1
92 Nef and TNFα are Coplayers that Favor HIV-1 Replication in Monocytic Cells and Primary Macrophages Current HIV Research Georges Herbein; Audrey Varin; Anis Larbi; Carl Fortin; Ulrich Mahlknecht; Tamas Fulop; Bharat B. Aggarwal 10.2174/157016208783884985 23
93 Endoradiotherapy with peptides - Status and future development Current Medicinal Chemistry Uwe Haberkorn; Michael Eisenhut; Annette Altmann; Walter Mier 10.2174/092986708783497256 23
94 Gender-Specific Distribution of Hematological Parameters in Adults Living in Nouna, Burkina Faso The Open Hematology Journal T. Böhler; Gisela Kynast-Wolf; B. Coulibaly; A. Siè; A. Kapaun 10.2174/1874276900802010001 2
95 Frequency and severity of aggressive incidents in acute psychiatric wards in Switzerland Clinical Practice And Epidemiology In Mental Health : CP & EMH Christoph Abderhalden; Ian Needham; Theo Dassen; Ruud J.G. Halfens; Joachim E. Fischer; Hans-Joachim Haug 10.1186/1745-0179-3-30 64
96 Mesenchymal Stromal Cells from Umbilical Cord Blood Current Stem Cell Research & Therapy Karen Bieback; Harald Klüter 10.2174/157488807782793763 136
97 Alterations in Cerebral Metabolomics and Proteomic Expression during Sepsis Current Neurovascular Research Jochen Hinkelbein; Robert E. Feldmann; Anna Peterka; Charlotte Schubert; Dominik W. Schelshorn; Martin H. Maurer; Armin Kalenka 10.2174/156720207782446388 24
98 Cyclooxygenase-2 (COX-2) : A Therapeutic Target in Liver Cancer? Current Pharmaceutical Design Marco Breinig; Peter Schirmacher; Michael A. Kern 10.2174/138161207782360627 39
99 Microcirculatory Endothelial Dysfunction During Endotoxemia - Insights into Pathophysiology, Pathologic Mechanisms and Clinical Relevance Current Vascular Pharmacology Marcus Czabanka; Christoph Peter; Eike Martin; Andreas Walther 10.2174/157016107782023389 42
100 Onconeural Versus Paraneoplastic Antigens Current Medicinal Chemistry Stefan B. Eichmüller; Alexandr V. Bazhin 10.2174/092986707782023668 11
101 Standards and Novel Therapeutic Options in the Treatment of Patients with Soft Tissue Sarcoma Reviews On Recent Clinical Trials Bernd Kasper 10.2174/157488707781662706 14
102 Molecular Pathogenesis of Pancreatic Cancer: Advances and Challenges Current Molecular Medicine Thilo Welsch; Jörg Kleeff; Helmut Friess 10.2174/156652407781387082 55
103 Perspectives for gene therapy of wilson disease Current Gene Therapy Uta Merle; Wolfgang Stremmel; Jens Encke 10.2174/156652307780859053 13
104 Radiolabeled peptides and proteins in cancer therapy. Protein And Peptide Letters Carmen Wängler; Inga Buchmann; Michael Eisenhut; Uwe Haberkorn; Walter Mier 10.2174/092986607780090874 24
105 Tyrosine Kinases as Therapeutic Targets in BCR-ABL Negative Chronic Myeloproliferative Disorders Current Drug Targets Andreas Reiter; Christoph Walz; Nicholas C.P. Cross 10.2174/138945007779940124 29
106 Artificial organs: a new option for treating osteoarthritis. Current Drug Delivery J. Stove; L. Lehmann; S. Fickert; T. Aigner; R. Brenner 10.2174/156720107779314839 0
107 Protein S-100B--a prognostic marker for cerebral damage Current Medicinal Chemistry Mark Stroick; Marc Fatar; Andreas Ragoschke-Schumm; Klaus Fassbender; Thomas Bertsch; Michael G. Hennerici 10.2174/092986706778521751 38
108 The Cardiac hERG/IKr Potassium Channel as Pharmacological Target: Structure, Function, Regulation, and Clinical Applications Current Pharmaceutical Design D. Thomas; C. A. Karle; Johann Kiehn 10.2174/138161206777585102 87
109 Screening the brain: molecular fingerprints of neural stem cells. Current Stem Cell Research & Therapy Martin H. Maurer; Wolfgang Kuschinsky 10.2174/157488806775269142 12
110 Dose-Intensive Chemotherapy with Stem Cell Support as a Treatment Strategy for Bone and Soft-Tissue Sarcomas Current Stem Cell Research & Therapy Bernd Kasper; Anthony D. Ho; Gerlinde Egerer 10.2174/157488806775269098 2
111 Novel molecular targets in the treatment of cardiac hypertrophy. Recent Patents On Cardiovascular Drug Discovery Mark Luedde; Hugo A. Katus; Norbert Frey 10.2174/157489006775244290 31
112 Drug Delivery Across the Blood-Brain Barrier Current Nanoscience Anika M.S. Hartz; Björn Bauer; Carsten H. Baehr; David Miller; Gert Fricker 10.2174/157341305774642948 1
113 The renin-angiotensin system in the mammalian central nervous system. Current Protein & Peptide Science null von Bohlen und Halbach O 10.2174/1389203054546361 35
114 Role of nitrosative stress and poly(ADP-ribose) polymerase activation in myocardial reperfusion injury. Current Vascular Pharmacology Gábor Szabó; Susanne Bährle 10.2174/1570161054368599 31
115 Scintigraphic imaging of gene expression and gene transfer. Current Medicinal Chemistry Uwe Haberkorn; Walter Mier; Michael Eisenhut 10.2174/0929867053507351 24
116 Influence of CYP2D6 Genetics on Opioid Kinetics, Metabolism and Response Current Pharmacogenomics Gerd Mikus; Johanna Weiss 10.2174/1570160053175018 23
117 Non-invasive treatment of critical limb ischemia. Current Drug Targets. Cardiovascular & Haematological Disorders Curt Diehm; Nicolas Diehm 10.2174/1568006043336069 14
118 Monitoring therapy with gene expression profiling reveals physiological differences in drug action. Current Pharmaceutical Design Stefan Wölfl; A. Burchert; T. Kroll 10.2174/1381612043384385 4
119 Antiangiogenic therapy in hematologic malignancies. Current Pharmaceutical Design Thomas Moehler; J. Hillengass; H Goldschmidt; A D Ho 10.2174/1381612043452587 26
120 Molecular Genetic of Human Male Infertility: From Genes to New Therapeutic Perspectives Current Pharmaceutical Design Peter H. Vogt 10.2174/1381612043453261 84
121 Endothelin Receptor Antagonists: A New Therapeutic Option for Improving the Outcome after Solid Organ Transplantation? Current Vascular Pharmacology Uwe Gottmann; Fokko J. van der Woude; Claude Braun 10.2174/1570161033476655 14
122 Nitric Oxide-Mediated Endothelial Dysfunction - Is there Need to Treat? Current Vascular Pharmacology Tiefenbacher Cp; Kreuzer J 10.2174/1570161033476718 19
123 Potential pharmacological applications of the antithrombotic molecule high molecular weight kininogen. Current Vascular Pharmacology Triantafyllos Chavakis; Klaus T. Preissner 10.2174/1570161033386790 7
124 The cardiotoxicity of local anesthetics: the place of ropivacaine. Current Topics In Medicinal Chemistry Bernhard M. Graf 10.2174/1568026013395164 61
125 Microarrays: spotlight on gene function and pharmacogenomics. Current Cancer Drug Targets Matthias Nees; Craig D. Woodworth 10.2174/1568009013334197 20
126 Aldosterone- and progesterone-membrane-binding proteins: new concepts of nongenomic steroid action. Current Protein & Peptide Science K. Haseroth; M. Christ; E. Falkenstein; M. Wehling 10.2174/1389203003381270 10
127 Modulation of the Ceramide Level, A Novel Therapeutic Concept Current Drug Targets Ralf A. Claus; Stefan Russwurm; M. Meisner; Ralf Kinscherf; Hans-Peter Deigner 10.2174/1389450003349272 35
128 Polymer - Nanoparticle Assemblies for Array Based Sensing. Current Organic Chemistry Brian Creran; Uwe H. F. Bunz; Vincent M. Rotello 4
129 Editorial: Multiple Myeloma Immunotherapies. Current Cancer Drug Targets Klaus Podar 10.2174/156800961709171005160041 0
130 Modulating apoptosis: current applications and prospects for future drug development. Current Medicinal Chemistry Hans-Peter Deigner; Ralf Kinscherf 44
Webmaster Contact: info@benthamscience.net
Copyright © 2020 Bentham Science